Haleon (HLN) broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon’s science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon Completes Acquisition of Remaining Stake in China JV
- Haleon Completes First Tranche of Share Buyback Program
- Haleon PLC Executes Share Buyback to Enhance Shareholder Value
- Haleon names Carl Haney as Chief Research & Development Officer
- Haleon price target raised to 503 GBp from 502 GBp at Berenberg